DEVELOPMENTAL ASPECTS OF THE MONOAMINE-DEGRADING ENZYME MONOAMINE-OXIDASE

被引:30
作者
BENEDETTI, MS
DOSTERT, P
TIPTON, KF
机构
[1] FARMITALIA CARLO ERBA SPA, R&D ERBAMONT GRP, MILAN, ITALY
[2] UNIV DUBLIN TRINITY COLL, DEPT BIOCHEM, DUBLIN 2, IRELAND
来源
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 1992年 / 18卷 / 3-4期
关键词
MONOAMINE OXIDASE; ONTOGENY; SPECIES DIFFERENCES;
D O I
10.1159/000480622
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the rat heart, monoamine oxidase (MAO)-B activity was shown to predominate in 2- to 3-week-old animals, whereas MAO-A activity was reported to be very low in newborn rats and to increase considerably with age until it predominates. These results are in contrast with those found in the mouse heart, where an age-dependent increase in MAO-B activity with no changes in 5-hydroxytryptamine deaminating activity was found to occur. There is evidence that the adult values of MAO activity are reached early in development in rat kidney and liver. In the rat lung the adult values of MAO-A activity are reached by day 40, whereas MAO-B activity is still increasing by day 80. Important differences have been reported in the developmental pattern of the two forms of MAO in the rat and mouse brain, with a decrease in the MAO-A/MAO-B ratio during postnatal development. In the human brain, the ontogenetic development of MAO-A and MAO-B appears to parallel that observed in the rodent brain. It is worth noting that most of the available data have to be considered with reservation owing to many methodological problems. Further studies are clearly needed to get reliable information on the ontogenesis of MAO in mammalian tissues.
引用
收藏
页码:191 / 200
页数:10
相关论文
共 48 条
  • [1] ANDERSON GM, 1985, J NEUROL NEUROSUR PS, V51, P1100
  • [2] MONOAMINE-OXIDASE, BRAIN AGING AND DEGENERATIVE DISEASES
    BENEDETTI, MS
    DOSTERT, P
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (04) : 555 - 561
  • [3] INTESTINAL METABOLISM OF TYRAMINE BY BOTH FORMS OF MONOAMINE-OXIDASE IN THE RAT
    BENEDETTI, MS
    BOUCHER, T
    CARLSSON, A
    FOWLER, CJ
    [J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (01) : 47 - 52
  • [4] BENEDETTI MS, IN PRESS J NEURAL TR
  • [5] BENEDETTI MS, 1988, PROG DRUG METAB, V11, P149
  • [6] BENEDETTI MS, 1991, BIOL PSYCHIAT, V1, P386
  • [7] ONTOGENESIS OF UPTAKE AND DEAMINATION OF 5-HYDROXYTRYPTAMINE, DOPAMINE AND BETA-PHENYLETHYLAMINE IN ISOLATED PERFUSED LUNG AND LUNG HOMOGENATES FROM RATS
    BENHARARI, RR
    YOUDIM, MBH
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1981, 72 (04) : 731 - 737
  • [8] ONTOGENESIS OF ENZYME-SYSTEMS DEAMINATING DIFFERENT MONOAMINES
    BLATCHFORD, D
    HOLZBAUER, M
    GRAHAMESMITH, DG
    YOUDIM, MBH
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1976, 57 (02) : 279 - 293
  • [9] 5-HYDROXYTRYPTAMINE CATABOLISM IN RAT-BRAIN DURING ONTOGENESIS
    BOURGOIN, S
    ARTAUD, F
    ADRIEN, J
    HERY, F
    GLOWINSKI, J
    HAMON, M
    [J]. JOURNAL OF NEUROCHEMISTRY, 1977, 28 (02) : 415 - 422
  • [10] CALLINGHAM BA, 1975, BRIT J PHARMACOL, V53, pP458